Closing thr #Biopharma skills gap! The most pressing challenges facing the biopharma industry and what needs to be done to tackle the growing problem: https://t.co/gAvfbgoAkr
Regeneron Pharmaceuticals and Sanofi have launched a Phase II/III clinical program in the U.S. evaluating the marketed arthritis drug Kevzara® as a treatment for severe #COVID19#Coronavirus infection in up to 400 patients: https://t.co/uvhcvnAiw2